name,category,terms6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4,INTERPRO[450001187$IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, 450002719$IPR003094:Fructose-2,6-bisphosphatase, 450011723$IPR013078:Phosphoglycerate mutase, 450011724$IPR013079:6-phosphofructo-2-kinase, 450014584$IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4,PIR_SUPERFAMILY[630000821$PIRSF000709:6PFK_2-Ptase, 630000822$PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000158$active site:Tele-phosphohistidine intermediate, 850000362$binding site:Fructose-6-phosphate, 850002501$chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 4, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110612$region of interest:6-phosphofructo-2-kinase, 850111707$region of interest:Fructose-2,6-bisphosphatase, 850117295$sequence variant]
ATG7 autophagy related 7 homolog (S. cerevisiae),INTERPRO[450000507$IPR000594:UBA/THIF-type NAD/FAD binding fold, 450005710$IPR006285:E1-like protein-activating enzyme Gsa7p/Apg7p, 450014426$IPR016040:NAD(P)-binding domain]
ATG7 autophagy related 7 homolog (S. cerevisiae),KEGG_PATHWAY[470038839$hsa04140:Regulation of autophagy]
ATG7 autophagy related 7 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000148$autophagy, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001266$protein transport, 790001558$transport, 790001593$ubl conjugation pathway]
ATG7 autophagy related 7 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850006890$chain:Autophagy-related protein 7, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
ATPase, Ca++ transporting, ubiquitous,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005235$IPR005782:ATPase, P-type, calcium-transporting, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, ubiquitous,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038891$hsa05010:Alzheimer's disease]
ATPase, Ca++ transporting, ubiquitous,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, ubiquitous,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001356$sarcoplasmic reticulum, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, ubiquitous,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850000242$binding site:ATP, 850058909$chain:Sarcoplasmic/endoplasmic reticulum calcium ATPase 3, 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
CD2 (cytoplasmic tail) binding protein 2,INTERPRO[450002786$IPR003169:GYF]
CD2 (cytoplasmic tail) binding protein 2,PIR_SUPERFAMILY[630029529$PIRSF037959:CD2 antigen cytoplasmic tail-binding protein 2]
CD2 (cytoplasmic tail) binding protein 2,SMART[760000390$SM00444:GYF]
CD2 (cytoplasmic tail) binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
CD2 (cytoplasmic tail) binding protein 2,UP_SEQ_FEATURE[850010131$chain:CD2 antigen cytoplasmic tail-binding protein 2, 850104094$domain:GYF, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
CMT1A duplicated region transcript 4,OMIM_DISEASE[520001932$Framingham Heart Study genome-wide association: results for pulmonary function measures]
CMT1A duplicated region transcript 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
CMT1A duplicated region transcript 4,UP_SEQ_FEATURE[850011728$chain:CMT1A duplicated region transcript 4 protein, 850117295$sequence variant]
DENN/MADD domain containing 4C,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
DENN/MADD domain containing 4C,UP_SEQ_FEATURE[850014833$chain:DENN domain-containing protein 4C, 850102581$compositionally biased region:Poly-Ser, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116805$repeat:PPR, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
HOP homeobox,BIOCARTA[30000140$h_hopPathway:Hop Pathway in Cardiac Development]
HOP homeobox,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
HOP homeobox,SMART[760000341$SM00389:HOX]
HOP homeobox,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000699$Homeobox, 790001065$nucleus, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
HOP homeobox,UP_SEQ_FEATURE[850024782$chain:Homeodomain-only protein, 850102933$DNA-binding region:Homeobox; atypical, 850117294$sequence conflict, 850118574$splice variant]
LanC lantibiotic synthetase component C-like 1 (bacterial),INTERPRO[450007171$IPR007822:Lanthionine synthetase C-like]
LanC lantibiotic synthetase component C-like 1 (bacterial),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000919$membrane, 790000937$metal-binding, 790001065$nucleus, 790001648$zinc]
LanC lantibiotic synthetase component C-like 1 (bacterial),UP_SEQ_FEATURE[850000375$binding site:Glutathione, 850027951$chain:LanC-like protein 1, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850111782$region of interest:Glutathione binding, 850118575$strand, 850118624$turn]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450014156$IPR015721:Rho GTP exchange factor]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,UP_SEQ_FEATURE[850057570$chain:Rho guanine nucleotide exchange factor 18, 850102586$compositionally biased region:Pro-rich, 850103518$domain:DH, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SAP30-like,PIR_SUPERFAMILY[630029985$PIRSF038453:histone deacetylase complex, SAP30/SAP30L subunits]
SAP30-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
SAP30-like,UP_SEQ_FEATURE[850023915$chain:Histone deacetylase complex subunit SAP30L, 850106258$modified residue, 850106259$mutagenesis site, 850118637$zinc finger region:Atypical]
SET domain containing 4,INTERPRO[450001068$IPR001214:SET, 450013794$IPR015353:Rubisco LSMT substrate-binding, 450015172$IPR016852:Lysine methylase, YDR198C, predicted]
SET domain containing 4,PIR_SUPERFAMILY[630020728$PIRSF027158:lysine methylase, YDR198C type, 630020729$PIRSF027158:Lys_MTase_YDR198C_prd]
SET domain containing 4,SMART[760000286$SM00317:SET]
SET domain containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
SET domain containing 4,UP_SEQ_FEATURE[850060452$chain:SET domain-containing protein 4, 850105340$domain:SET, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SON DNA binding protein,INTERPRO[450000396$IPR000467:D111/G-patch, 450001016$IPR001159:Double-stranded RNA binding, 450013172$IPR014720:Double-stranded RNA-binding-like]
SON DNA binding protein,SMART[760000326$SM00358:DSRM, 760000389$SM00443:G_patch]
SON DNA binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
SON DNA binding protein,UP_SEQ_FEATURE[850047769$chain:Protein SON, 850103545$domain:DRBM, 850104022$domain:G-patch, 850106258$modified residue, 850109795$region of interest:11 X 7 AA tandem repeats of [DR]-P-Y-R- [LI][AG][QHP], 850109870$region of interest:14 X 6 AA repeats of [ED]-R-S-M-M-S, 850109918$region of interest:17 X 10 AA tandem repeats of L-A-[ST]- [NSG]-[TS]-MDSQM, 850109990$region of interest:2 X 19 AA repeats of P-S-R-R-R-R-S-R-S-V- V-R-R-R-S-F-S-I-S, 850110193$region of interest:3 X 11 AA tandem repats of P-P-L-P-P-E-E- P-P-[TME]-[MTG], 850110291$region of interest:3 X tandem repeats of [ST]-P-[VLI]-R- [RL]-[RK]-[RF]-S-R, 850110418$region of interest:4 X 8 AA tandem repeats of V-L-E-SS- [AVT]-VT, 850110672$region of interest:7 X 7 AA repeats of P-S-R-R-S-R-[TS], 850115075$repeat:1-1, 850115076$repeat:1-10, 850115078$repeat:1-11, 850115080$repeat:1-12, 850115082$repeat:1-13, 850115083$repeat:1-14, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850115119$repeat:1-6, 850115122$repeat:1-7, 850115124$repeat:1-8, 850115126$repeat:1-9, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850115315$repeat:2-4, 850115317$repeat:2-5, 850115320$repeat:2-6, 850115322$repeat:2-7, 850115418$repeat:3-1, 850115430$repeat:3-2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Sp6 transcription factor,COG_ONTOLOGY[90000073$General function prediction only]
Sp6 transcription factor,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Sp6 transcription factor,SMART[760000323$SM00355:ZnF_C2H2]
Sp6 transcription factor,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Sp6 transcription factor,UP_SEQ_FEATURE[850065345$chain:Transcription factor Sp6, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
THO complex 5,INTERPRO[450017409$IPR019163:THO complex,  subunit 5]
THO complex 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001558$transport]
THO complex 5,UP_SEQ_FEATURE[850064317$chain:THO complex subunit 5 homolog, 850106258$modified residue, 850112220$region of interest:Interaction with CSF1R, 850112946$region of interest:Interaction with THOC7, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,INTERPRO[450002359$IPR002659:Glycosyl transferase, family 31]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,KEGG_PATHWAY[470038773$hsa00533:Keratan sulfate biosynthesis, 470038784$hsa00601:Glycosphingolipid biosynthesis]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,UP_SEQ_FEATURE[850033198$chain:N-acetyllactosaminide beta-1,3-N- acetylglucosaminyltransferase, 850068196$chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
activating transcription factor 7 interacting protein 2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
activating transcription factor 7 interacting protein 2,UP_SEQ_FEATURE[850003666$chain:Activating transcription factor 7- interacting protein 2, 850103799$domain:Fibronectin type-III, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat and LEM domain containing 1,INTERPRO[450001870$IPR002110:Ankyrin, 450003412$IPR003887:Lamino-associated polypeptide 2/emerin]
ankyrin repeat and LEM domain containing 1,SMART[760000220$SM00248:ANK, 760000480$SM00540:LEM]
ankyrin repeat and LEM domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat and LEM domain containing 1,UP_SEQ_FEATURE[850005330$chain:Ankyrin repeat and LEM domain-containing protein 1, 850102566$compositionally biased region:Poly-Arg, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 12,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 12,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 12,UP_SEQ_FEATURE[850005362$chain:Ankyrin repeat domain-containing protein 12, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium channel, voltage-dependent, L type, alpha 1F subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004905$IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, L type, alpha 1F subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038845$hsa04270:Vascular smooth muscle contraction, 470038883$hsa04912:GnRH signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, L type, alpha 1F subunit,OMIM_DISEASE[520000189$Aland Island eye disease, 520001161$Cone-rod dystrophy, X-linked, 3, 520003657$Night blindness, congenital stationary, X-linked, type 2, 520003658$Night blindness, congenital stationary, X-linked, type 2A, 520003738$Ocular albinism, Forsius-Eriksson type]
calcium channel, voltage-dependent, L type, alpha 1F subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000366$Congenital stationary night blindness, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,UP_SEQ_FEATURE[850100534$chain:Voltage-dependent L-type calcium channel subunit alpha-1F, 850102572$compositionally biased region:Poly-Glu, 850102575$compositionally biased region:Poly-Ile, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850111436$region of interest:Dihydropyridine binding, 850114003$region of interest:Phenylalkylamine binding, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calumenin,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calumenin,PIR_SUPERFAMILY[630027762$PIRSF036326:reticulocalbin]
calumenin,SMART[760000046$SM00054:EFh]
calumenin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001356$sarcoplasmic reticulum, 790001363$Secreted, 790001405$signal]
calumenin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000628$calcium-binding region:3; possibly ancestral, 850000630$calcium-binding region:4, 850000631$calcium-binding region:5, 850000632$calcium-binding region:6, 850009221$chain:Calumenin, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850103589$domain:EF-hand 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant]
caspase 8, apoptosis-related cysteine peptidase,BBID[10000037$150.caspase_and_NFKB_activation, 10000063$39.Deg_of_Chromosomal_DNA, 10000065$40.Deg_of_Chrom_DNA_TNF-ind_apoptosis, 10000067$44.Sig_Trans_TNFR1-DR3-DR4_DR5, 10000068$46.P13K_PTEN, 10000093$72.IAP_interaction_with_cell_death_pathways, 10000108$86.Apoptosis_Nematode&_Vert]
caspase 8, apoptosis-related cysteine peptidase,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000274$h_soddPathway:SODD/TNFR1 Signaling Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
caspase 8, apoptosis-related cysteine peptidase,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450001895$IPR002138:Peptidase C14, caspase non-catalytic subunit p10, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core, 450014488$IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site]
caspase 8, apoptosis-related cysteine peptidase,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway, 470038843$hsa04210:Apoptosis, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038923$hsa05416:Viral myocarditis]
caspase 8, apoptosis-related cysteine peptidase,OMIM_DISEASE[520000487$Autoimmune lymphoproliferative syndrome, type IIB, 520000688$Breast cancer, protection against, 520002293$Hepatocellular carcinoma, somatic, 520002967$Lung cancer, protection against]
caspase 8, apoptosis-related cysteine peptidase,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030828$PIRSF500656:caspase-8]
caspase 8, apoptosis-related cysteine peptidase,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
caspase 8, apoptosis-related cysteine peptidase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001509$thiol protease, 790001652$zymogen]
caspase 8, apoptosis-related cysteine peptidase,UP_SEQ_FEATURE[850009845$chain:Caspase-8 subunit p10, 850009847$chain:Caspase-8 subunit p18, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
chorionic somatomammotropin hormone 1 (placental lactogen),INTERPRO[450001245$IPR001400:Somatotropin hormone, 450011046$IPR012351:Four-helical cytokine, core, 450016416$IPR018116:Somatotropin hormone, conserved site]
chorionic somatomammotropin hormone 1 (placental lactogen),KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
chorionic somatomammotropin hormone 1 (placental lactogen),OMIM_DISEASE[520004016$Placental lactogen deficiency]
chorionic somatomammotropin hormone 1 (placental lactogen),PIR_SUPERFAMILY[630001964$PIRSF001825:prolactin/lactogen/growth hormone]
chorionic somatomammotropin hormone 1 (placental lactogen),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000708$hormone, 790001189$placenta, 790001363$Secreted, 790001405$signal]
chorionic somatomammotropin hormone 1 (placental lactogen),UP_SEQ_FEATURE[850011302$chain:Chorionic somatomammotropin hormone, 850102883$disulfide bond, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chromosome 16 open reading frame 91,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 16 open reading frame 91,UP_SEQ_FEATURE[850045349$chain:Protein CCSMST1, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 17 open reading frame 79,SP_PIR_KEYWORDS[790000012$acetylation, 790000311$chromatin regulator, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
chromosome 17 open reading frame 79,UP_SEQ_FEATURE[850012520$chain:Cooperator of PRMT5, 850106258$modified residue, 850117295$sequence variant]
chromosome 3 open reading frame 23,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 3 open reading frame 23,UP_SEQ_FEATURE[850074075$chain:Uncharacterized protein C3orf23, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 3 open reading frame 54,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 3 open reading frame 54,UP_SEQ_FEATURE[850074094$chain:Uncharacterized protein C3orf54, 850102572$compositionally biased region:Poly-Glu]
citron (rho-interacting, serine/threonine kinase 21),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
citron (rho-interacting, serine/threonine kinase 21),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001035$IPR001180:Citron-like, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450015732$IPR017405:Citron Rho-interacting kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
citron (rho-interacting, serine/threonine kinase 21),PIR_SUPERFAMILY[630029748$PIRSF038145:citron Rho-interacting kinase, 630029749$PIRSF038145:Citron_Rho-interacting_kinase]
citron (rho-interacting, serine/threonine kinase 21),SMART[760000028$SM00036:CNH, 760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
citron (rho-interacting, serine/threonine kinase 21),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000937$metal-binding, 790000973$mitosis, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001399$sh3-binding, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
citron (rho-interacting, serine/threonine kinase 21),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850011548$chain:Citron Rho-interacting kinase, 850103028$domain:AGC-kinase C-terminal, 850103376$domain:CNH, 850104979$domain:PH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112777$region of interest:Interaction with Rho/Rac, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
coiled-coil domain containing 52,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 52,UP_SEQ_FEATURE[850012023$chain:Coiled-coil domain-containing protein 52, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
cold inducible RNA binding protein,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cold inducible RNA binding protein,SMART[760000328$SM00360:RRM]
cold inducible RNA binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001307$repressor, 790001339$rna-binding, 790001450$stress response]
cold inducible RNA binding protein,UP_SEQ_FEATURE[850012147$chain:Cold-inducible RNA-binding protein, 850102517$compositionally biased region:Gly-rich, 850105211$domain:RRM, 850105852$helix, 850118575$strand]
egf-like module containing, mucin-like, hormone receptor-like 2,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001543$IPR001740:GPCR, family 2, EMR1 hormone receptor, 450001663$IPR001881:EGF-like calcium-binding, 450002683$IPR003056:GPCR, family 2, CD97 antigen, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
egf-like module containing, mucin-like, hormone receptor-like 2,PIR_SUPERFAMILY[630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
egf-like module containing, mucin-like, hormone receptor-like 2,SMART[760000153$SM00179:EGF_CA, 760000273$SM00303:GPS]
egf-like module containing, mucin-like, hormone receptor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
egf-like module containing, mucin-like, hormone receptor-like 2,UP_SEQ_FEATURE[850016996$chain:EGF-like module-containing mucin-like hormone receptor-like 2, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
engulfment and cell motility 1,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450006220$IPR006816:Engulfment and cell motility, ELMO, 450010818$IPR011993:Pleckstrin homology-type]
engulfment and cell motility 1,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway]
engulfment and cell motility 1,OMIM_DISEASE[520001988$Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population]
engulfment and cell motility 1,SMART[760000205$SM00233:PH]
engulfment and cell motility 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001136$phagocytosis, 790001162$phosphoprotein, 790001399$sh3-binding]
engulfment and cell motility 1,UP_SEQ_FEATURE[850017449$chain:Engulfment and cell motility protein 1, 850103713$domain:ELMO, 850104979$domain:PH, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118575$strand, 850118624$turn]
exosome component 7,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
exosome component 7,INTERPRO[450001098$IPR001247:Exoribonuclease, phosphorolytic domain 1, 450014270$IPR015847:Exoribonuclease, phosphorolytic domain 2]
exosome component 7,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 7,PIR_SUPERFAMILY[630006618$PIRSF006657:exosome complex 3'-5' exonuclease]
exosome component 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
exosome component 7,UP_SEQ_FEATURE[850018277$chain:Exosome complex exonuclease RRP42, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
family with sequence similarity 134, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001020$neuropathy, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 134, member B,UP_SEQ_FEATURE[850045871$chain:Protein FAM134B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 40, member B,INTERPRO[450011166$IPR012486:N1221-like]
family with sequence similarity 40, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 40, member B,UP_SEQ_FEATURE[850045982$chain:Protein FAM40B, 850102576$compositionally biased region:Poly-Leu, 850117295$sequence variant, 850118574$splice variant]
glycoprotein Ib (platelet), alpha polypeptide,COG_ONTOLOGY[90000070$Function unknown]
glycoprotein Ib (platelet), alpha polypeptide,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
glycoprotein Ib (platelet), alpha polypeptide,KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage]
glycoprotein Ib (platelet), alpha polypeptide,OMIM_DISEASE[520000552$Bernard-Soulier syndrome, benign autosomal dominant, 520000553$Bernard-Soulier syndrome, type A, 520003672$Nonarteritic anterior ischemic optic neuropathy, susceptibility to, 520005056$von Willebrand disease, platelet-type]
glycoprotein Ib (platelet), alpha polypeptide,PIR_SUPERFAMILY[630002611$PIRSF002493:platelet glycoprotein Ib alpha chain]
glycoprotein Ib (platelet), alpha polypeptide,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
glycoprotein Ib (platelet), alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000175$bernard soulier syndrome, 790000192$blood coagulation, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000666$hemostasis, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001207$platelet membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001461$sulfation, 790001484$tandem repeat, 790001517$thrombin binding, 790001555$transmembrane, 790001556$transmembrane protein, 790001634$von Willebrand disease, 790001635$von Willebrand factor binding]
glycoprotein Ib (platelet), alpha polypeptide,UP_SEQ_FEATURE[850022037$chain:Glycocalicin, 850039522$chain:Platelet glycoprotein Ib alpha chain, 850102595$compositionally biased region:Pro/Thr-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
gonadotropin-releasing hormone 2,INTERPRO[450001783$IPR002012:Gonadotropin-releasing hormone, 450018024$IPR019792:Gonadoliberin I]
gonadotropin-releasing hormone 2,KEGG_PATHWAY[470038883$hsa04912:GnRH signaling pathway]
gonadotropin-releasing hormone 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000708$hormone, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
gonadotropin-releasing hormone 2,UP_SEQ_FEATURE[850044489$chain:Progonadoliberin-2, 850106258$modified residue, 850107748$peptide:GnRH-associated peptide 2, 850107757$peptide:Gonadoliberin-2, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,INTERPRO[450001568$IPR001770:G-protein, gamma subunit, 450014319$IPR015898:G-protein, gamma-like subunit]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,PIR_SUPERFAMILY[630002518$PIRSF002398:GTP-binding regulatory protein gamma chain]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,SMART[760000196$SM00224:GGL]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001236$prenylation, 790001546$transducer]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,UP_SEQ_FEATURE[850022727$chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2, 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
heterogeneous nuclear ribonucleoprotein A/B,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450011632$IPR012956:CARG-binding factor, N-terminal]
heterogeneous nuclear ribonucleoprotein A/B,PIR_SUPERFAMILY[630002201$PIRSF002072:helix-destabilizing protein]
heterogeneous nuclear ribonucleoprotein A/B,SMART[760000328$SM00360:RRM]
heterogeneous nuclear ribonucleoprotein A/B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001613$viral nucleoprotein]
heterogeneous nuclear ribonucleoprotein A/B,UP_SEQ_FEATURE[850023567$chain:Heterogeneous nuclear ribonucleoprotein A/B, 850102517$compositionally biased region:Gly-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850118574$splice variant]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,PIR_SUPERFAMILY[630002184$PIRSF002050:histone H2B]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,SMART[760000373$SM00427:H2B]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,SP_PIR_KEYWORDS[790000012$acetylation, 790000092$antibiotic, 790000100$Antimicrobial, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,UP_SEQ_FEATURE[850024021$chain:Histone H2B type 1-C/E/F/G/I, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
hook homolog 2 (Drosophila),INTERPRO[450007894$IPR008636:HOOK]
hook homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
hook homolog 2 (Drosophila),UP_SEQ_FEATURE[850046430$chain:Protein Hook homolog 2, 850106258$modified residue, 850114416$region of interest:Required for localization to the centrosome and induction of aggresome formation, 850114747$region of interest:Sufficient for interaction with CEP110, 850114780$region of interest:Sufficient for interaction with microtubules, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),INTERPRO[450001972$IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase, 450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450014426$IPR016040:NAD(P)-binding domain]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038847$hsa04320:Dorso-ventral axis formation]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),OMIM_DISEASE[520000990$Cholestasis, progressive familial intrahepatic 4]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),PIR_SUPERFAMILY[630028161$PIRSF036679:bifunctional 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, 630029992$PIRSF038460:piwi protein]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000790$intrahepatic cholestasis, 790000915$meiosis, 790000919$membrane, 790000953$methylation, 790001006$nad, 790001077$oogenesis, 790001092$oxidoreductase, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001426$spermatogenesis, 790001444$steroidogenesis, 790001551$translation regulation, 790001555$transmembrane]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850001374$chain:3 beta-hydroxysteroid dehydrogenase type 7, 850039216$chain:Piwi-like protein 2, 850104911$domain:PAZ, 850105001$domain:Piwi, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
interleukin 17 receptor C,INTERPRO[450012192$IPR013568:SEFIR]
interleukin 17 receptor C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
interleukin 17 receptor C,UP_SEQ_FEATURE[850026537$chain:Interleukin-17 receptor C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 17B,INTERPRO[450009410$IPR010345:Interleukin-17]
interleukin 17B,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
interleukin 17B,PIR_SUPERFAMILY[630003490$PIRSF003430:interleukin-17, 630031173$PIRSF501047:interleukin-17B]
interleukin 17B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
interleukin 17B,UP_SEQ_FEATURE[850026541$chain:Interleukin-17B, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
jumonji domain containing 8,INTERPRO[450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase]
jumonji domain containing 8,SMART[760000497$SM00558:JmjC]
jumonji domain containing 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
jumonji domain containing 8,UP_SEQ_FEATURE[850026965$chain:JmjC domain-containing protein 8, 850104488$domain:JmjC, 850117294$sequence conflict, 850118574$splice variant]
jun B proto-oncogene,BBID[10000018$114.Genomic_reformatting_Brain_Ischemia]
jun B proto-oncogene,BIOCARTA[30000123$h_GATA3pathway:GATA3 participate in activating the Th2 cytokine genes expression]
jun B proto-oncogene,INTERPRO[450001871$IPR002112:Transcription factor Jun, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450005091$IPR005643:Jun-like transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
jun B proto-oncogene,PIR_SUPERFAMILY[630001864$PIRSF001718:transcription factor AP-1]
jun B proto-oncogene,SMART[760000306$SM00338:BRLZ]
jun B proto-oncogene,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
jun B proto-oncogene,UP_SEQ_FEATURE[850065216$chain:Transcription factor jun-B, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
keratin 13,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 13,OMIM_DISEASE[520005089$White sponge nevus]
keratin 13,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 13,UP_SEQ_FEATURE[850027173$chain:Keratin, type I cytoskeletal 13, 850102517$compositionally biased region:Gly-rich, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
keratin 78,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 78,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 78,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001212$polymorphism]
keratin 78,UP_SEQ_FEATURE[850027222$chain:Keratin, type II cytoskeletal 78, 850102517$compositionally biased region:Gly-rich, 850102597$compositionally biased region:Ser-rich, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter, 850118574$splice variant]
late cornified envelope 2B,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 2B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 2B,UP_SEQ_FEATURE[850028027$chain:Late cornified envelope protein 2B, 850102480$compositionally biased region:Cys-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
macrophage erythroblast attacher,INTERPRO[450006014$IPR006594:LisH dimerisation motif, 450006015$IPR006595:CTLH, C-terminal to LisH motif, 450011782$IPR013144:Ran binding protein-like, CRA domain]
macrophage erythroblast attacher,SMART[760000580$SM00667:LisH, 760000581$SM00668:CTLH, 760000663$SM00757:CRA]
macrophage erythroblast attacher,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000513$erythrocyte maturation, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism]
macrophage erythroblast attacher,UP_SEQ_FEATURE[850029485$chain:Macrophage erythroblast attacher, 850103431$domain:CTLH, 850104733$domain:LisH, 850111654$region of interest:Extracellular and involved in cell to cell contact, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
methyltransferase like 11A,INTERPRO[450007842$IPR008576:Protein of unknown function DUF858, methyltransferase-like]
methyltransferase like 11A,PIR_SUPERFAMILY[630013736$PIRSF016958:DUF858_MeTrfase_lik, 630013737$PIRSF016958:S-adenosyl-L-methionine dependent methyltransferase, AD-003 type]
methyltransferase like 11A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000954$methyltransferase, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
methyltransferase like 11A,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850031557$chain:Methyltransferase-like protein 11A, 850105852$helix, 850106258$modified residue, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
misato homolog 1 (Drosophila),INTERPRO[450002643$IPR003008:Tubulin/FtsZ, GTPase domain, 450017842$IPR019605:Misato Segment II, myosin-like]
misato homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001162$phosphoprotein, 790001212$polymorphism]
misato homolog 1 (Drosophila),UP_SEQ_FEATURE[850046888$chain:Protein misato homolog 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitochondrial ribosomal protein S28,INTERPRO[450017613$IPR019375:Ribosomal protein S35, mitochondrial]
mitochondrial ribosomal protein S28,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein S28,UP_SEQ_FEATURE[850001326$chain:28S ribosomal protein S28, mitochondrial, 850106258$modified residue, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
mitochondrial ribosomal protein S36,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001162$phosphoprotein, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
mitochondrial ribosomal protein S36,UP_SEQ_FEATURE[850001333$chain:28S ribosomal protein S36, mitochondrial, 850106258$modified residue]
mitogen-activated protein kinase kinase 2 pseudogene; mitogen-activated protein kinase kinase 2,BBID[10000003$100.MAPK_signaling_cascades]
